CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,277,000 | -11.1% | 49,810 | -17.6% | 0.08% | +13.0% |
Q2 2022 | $1,437,000 | -46.0% | 60,418 | -48.8% | 0.07% | -53.7% |
Q1 2022 | $2,659,000 | +3.4% | 118,063 | -9.1% | 0.15% | +55.2% |
Q4 2021 | $2,571,000 | +29.0% | 129,857 | +28.2% | 0.10% | -6.8% |
Q3 2021 | $1,993,000 | +143.3% | 101,295 | +172.0% | 0.10% | +194.3% |
Q2 2021 | $819,000 | -52.5% | 37,247 | -48.6% | 0.04% | -63.5% |
Q1 2021 | $1,725,000 | +175.1% | 72,495 | +94.4% | 0.10% | -7.7% |
Q2 2020 | $627,000 | +69.5% | 37,295 | +21.9% | 0.10% | +246.7% |
Q4 2019 | $370,000 | -69.9% | 30,600 | -64.9% | 0.03% | -60.0% |
Q3 2019 | $1,231,000 | +281.1% | 87,100 | +200.3% | 0.08% | +167.9% |
Q2 2019 | $323,000 | -60.9% | 29,000 | -58.8% | 0.03% | -77.6% |
Q1 2019 | $826,000 | +216.5% | 70,400 | +261.0% | 0.12% | +62.3% |
Q4 2018 | $261,000 | – | 19,500 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |